• Contractor
  • Anywhere

WHO - World Health Organization


Global HIV, Hepatitis and STIs Programme (research and development of new therapeutics for pregnant and breastfeeding women)

( 2205848 )

Contractual Arrangement : External consultant

Contract Duration (Years, Months, Days) : 11 months – part-time at 50%

Job Posting: Jun 24, 2022, 12:35:27 PM

Purpose of consultancy

To provide technical expertise to the Global HIV, Hepatitis and STIs Programmes work research and development of new therapeutics for pregnant and breastfeeding women.


Multiple agencies and actors have voiced their concerns around the exclusion of pregnant and breastfeeding women from clinical trials and the associated harm and risks of these policies. More recently, the importance of allowing pregnant women the opportunity to take part in clinical trials has received renewed attention during the COVID-19 pandemic. In this context, a technical body of experts on investigation and use of drugs in pregnant women for the prevention and treatment of HIV, Hepatitis and STIs is needed to advise WHO in its Guidelines development, their implementation and more broadly the drug optimization work that will accelerate innovation and access for this population.

In this context, several activities will be undertaken by the HHS Department to accelerate investigation of new therapeutics and their safe use for pregnant breastfeeding women. The contractual partner will be working with the WHO HHS/SIA unit to assist the work of the newly established HIV, Hepatitis and STIs Pregnancy and Breastfeeding Therapeutics Working Group (HHS PTWG). The aims of the technical working group will be to provide expert advice and inform WHO on matters that relate to the use of recommended medicines as well as to research and development of new therapeutics in pregnant and breastfeeding women for prevention and treatment of HIV, Hepatitis and STIs. The consultant will assist in finalizing the terms of reference and workplan of key areas of work for the technical working group, organizing the modalities and operations for establishing the group, preparing meetings, and regularly reviewing resources and making them available to the group members. The consultant will assist in drafting a toolkit for research in pregnancy in support of investigators and key stakeholders including an inventory of protocols and studies. The consultant will also assist in preparing dissemination materials for communication and advocacy purposes, including researchers, technical partners, regulatory authorities, civil society, private sector engaged in research and innovation, and national programmes engaged with clinical trials and surveillance programmes.


Output 1: Development of PTWG terms of reference, governance and workplan

  • Deliverable 1.1: Draft terms of reference. Expected by: 30 July 2022;
  • Deliverable 1.2: Draft Workplan. Expected by: 15 August 2022;
  • Deliverable 1.3: Draft virtual resource folder including DOIs and appropriate mapping of PTWG members. Expected by: 30 August 2022.

Output 2: PTWG meetings, design and facilitation of core activities identified by the PTWG.

  • Deliverable 2.1: Draft agenda, slides, and dissemination material for bimonthly calls. (Q2, Q3 and Q4). Expected by: 30 September 2022;
  • Deliverable 2.2: Draft study implementation repository (trials and surveillance, registries, eHealth). Expected by: 30 October 2022;
  • Deliverable 2.3: Draft updated tracker with ongoing studies (trials, surveillance, registries, eHealth.) Expected by: 30 November 2022.

Output 3: Update and development of the pregnancy chapter for the R&D toolkit

  • Deliverable 3.1: Draft concept note, project plan, and detailed outline. Expected by: 30 January 2023;
  • Deliverable 3.2: Draft updated pregnancy chapter. Expected by 30 March 2023.

Output 4: Design and development of dissemination materials of the TWG work

  • Deliverable 4.1: Draft dissemination materials. Expected by: 30 April 2023;
  • Deliverable 4.2: Provide final draft of dissemination materials. Expected by: 15 May 2023;
  • Deliverable 4.3: Prepare slides set for presentation to CADO and contribution to final report. Expected by: 30 May 2023.

Qualifications, experience, skills and languages

Educational Qualifications:

Essential: Advanced degree in medicine or pharmacy and/or postgraduate qualification in obstetrics, epidemiology, or public health


Essential: Over 10 years’ experience in maternal, child and infant HIV infection and treatment of which at least 7 years in scientific research and clinical studies.


  • At least five years of experience in investigating the use of medicines in pregnant and breastfeeding women living with HIV.
  • At least 5 years’ experience with clinical trial design, observational data, or surveillance in HIV, Hep or STIs.
  • Previous experience with WHO on drug optimization and surveillance work.


  • Basic knowledge of human rights, community engagement and gender equity in relation to disease response.
  • Expertise in contributing in collaborative projects.
  • Good communication and presentation skills.

Languages required:

Essential: Expert knowledge of English.



Home Based


No travel is expected.

Remuneration and budget (travel costs are excluded):

Remuneration: Payband level C

USD 10,000

12,500 per month

Living expenses (A living expense is payable to on-site consultants who are internationally recruited):


Expected duration of contract (Maximum contract duration is 11 months per calendar year):

11 months – part-time at 50%

Additional Information

  • This vacancy notice may be used to identify candidates for other similar consultancies at the same level.
  • Only candidates under serious consideration will be contacted.
  • A written test may be used as a form of screening.
  • If your candidature is retained for interview, you will be required to provide, in advance, a scanned copy of the degree(s)/diploma(s)/certificate(s) required for this position. WHO only considers higher educational qualifications obtained from an institution accredited/recognized in the World Higher Education Database (WHED), a list updated by the International Association of Universities (IAU)/United Nations Educational, Scientific and Cultural Organization (UNESCO). The list can be accessed through the link: (link) Some professional certificates may not appear in the WHED and will require individual review.
  • For information on WHO’s operations please visit: (link)
  • WHO is committed to workforce diversity.
  • WHO has a smoke-free environment and does not recruit smokers or users of any form of tobacco.
  • Applications from women and from nationals of non and underrepresented Member States are particularly encouraged.
  • WHO prides itself on a workforce that adheres to the highest ethical and professional standards and that is committed to put the WHO Values Charter into practice.
  • WHO has zero tolerance towards sexual exploitation and abuse (SEA), sexual harassment and other types of abusive conduct (i.e., discrimination, abuse of authority and harassment). All members of the WHO workforce have a role to play in promoting a safe and respectful workplace and should report to WHO any actual or suspected cases of SEA, sexual harassment and other types of abusive conduct. To ensure that individuals with a substantiated history of SEA, sexual harassment or other types of abusive conduct are not hired by the Organization, WHO will conduct a background verification of final candidates.
  • Consultants shall perform the work as independent contractors in a personal capacity, and not as a representative of any entity or authority. The execution of the work under a consultant contract does not create an employer/employee relationship between WHO and the Consultant.
  • WHO shall have no responsibility whatsoever for any taxes, duties, social security contributions or other contributions payable by the Consultant. The Consultant shall be solely responsible for withholding and paying any taxes, duties, social security contributions and any other contributions which are applicable to the Consultant in in each location/jurisdiction in which the work hereunder is performed, and the Consultant shall not be entitled to any reimbursement thereof by WHO.
  • Consultants working in Switzerland must register with the applicable Swiss cantonal tax authorities and social security authorities, within the prescribed timeframes (Guidelines issued by the Swiss Mission are available at: (link)-onu-geneve/en/home/manual-regime-privileges-and-immunities/introduction/Manuel-personnes-sans-privileges-et-immunites-carte-H/Non fonctionnaires et stagiaires.html
Tags: breastfeeding, covid, human rights, pharmacy, research and development, scientific research, social security contributions